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Introduction
As a consequence of the auscultatory method, blood pressure (BP) measurements 
were classically obtained from the definition of specific points on the BP pulsatile 
curve: peak systolic blood pressure (SBP) and end-diastolic blood pressure (DBP) 
(Fig. 12.1) |1–3|. Later, following the results of therapeutic trials in hypertension, it 
was proposed that cardiovascular risk could be much better evaluated from SBP 
than from DBP. In fact, all these classical definitions are largely oversimplified.
Blood pressure is the force applied per unit area on a given vessel, which 
determines the flow of blood. Pressure and flow result from the properties of the 
heart as a pump and the characteristics of the arterial system. However, pressure 
and flow vary during the cardiac cycle and are therefore called pulsatile pressure 
and flow. When the BP curve is submitted to Fourier analysis and written as a series 
of sine waves, they are called oscillatory pressure and flow. The zero term equals 
Pressure
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fig. 12.1 The different components of the pulsatile BP curve |1–3|. For MAP, the area 
under the curve is exactly equal to the area under the pulsatile BP curve, which means 
that the two curves are able to produce the same cardiac work |1–3|.
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the mean value (mean arterial pressure, MAP) (see Fig. 12.1) and the harmonics 
are the oscillatory terms, summarized by pulse pressure (PP = SBP – DBP) (see Fig. 
12.1).
At the end of the Second World War, a group of cardiovascular physiologists 
|1–3| suggested that the pulsatile BP curve could be better described when divided 
into two components: a steady component, MAP, and a pulsatile component, pulse 
pressure (see Fig. 12.1) |1,3|. At a given cardiac function, the steady component, 
which corresponds to steady flow, as delivered theoretically by a steady pump 
(here, corresponding to the heart), relates to the status of small arteries, that is total 
vascular resistance, the ratio between MAP and blood flow. On the other hand, 
pulse pressure, which corresponds to the pulsatile flow actually ejected by the 
heart, is influenced by two distinct factors of the arterial system: stiffness and wave 
reflections.
Pressure and flow waves are not transmitted instantaneously to the periphery 
because of the elasticity of the aorta and the major conduit arteries. Rather, they 
propagate through the arterial tree with a certain speed, which we call pulse wave 
velocity (PWV). The distance travelled by the wave over the time delay gives the 
wave speed, as schematically drawn in Fig. 12.2, which typically varies between 
4 and 14 m/s. The wave speed pertains to pulsatile phenomena, and depends on 
vessel size and vessel elasticity: the higher the PWV, the lower the vessel elasticity 
and the higher the vascular stiffness.
Wave reflection takes place at all bifurcations and discontinuities of the 
vasculature (Fig. 12.3). However, it turns out that the major reflections occur at 
the arterioles, that is in the periphery, where many bifurcations are present over 
short distances. The degree of reflection is often related to a specific parameter: the 
∆T
Pulse wave velocity
PWV = L/∆T
Distensibility
D = (3.57/PWV)2
Carotid
L
Aorta
fig. 12.2 Clinical determination of pulse wave velocity (PWV) |1–4|. PWV is the ratio 
between: 1/the distance between the carotid and femoral transducers (L), and 2/the 
time delay (∆T) between the foot of the carotid and femoral blood pressure (BP) curves 
simultaneously measured |4|. From PWV, distensibility may be deduced |1–4|.
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fig. 12.3 A classical and simple model for the definition of arterial stiffness and wave 
reflections. Top: a normal youthful arterial tree. Bottom: a stiffened arterial tree of an 
older person. The reflection of the pressure wave is represented by the diastolic wave in 
the first case (a) and by the late systolic wave in the second (b). Coronary arteries are 
represented by ‘hooks’. Pulse wave velocity (PWV) is an index of arterial stiffness and is 
dependent on degree of rigidity (thin line or thick line) of the arterial wall |1–3|.
augmentation index (AIx). The AIx can be determined non-invasively (Fig. 12.4), 
and calibration of the signal is not required, so that applanation tonometry can be 
used for its determination. The AIx at a given heart rate depends not only on the 
magnitude of the reflected wave, but also on the time of return, which limits its 
interpretation.
Young Old
Augmentation
index
fig. 12.4 Augmentation index (Aix) is the ratio between: (1) the difference between 
peak systolic blood pressure (sBP) and the shoulder of the ascending part of the blood 
pressure (BP) curve, and (2) pulse pressure |1–4|. Aix, measured in %, represents the 
supplementary increase in sBP due to wave reflections. This hemodynamic profile is 
observed in the elderly, not in young people.
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In the present chapter, all these conceptual approaches will be applied to the 
clinical management of SBP and PP in subjects with hypertension, as published 
recently |1–3|.
Epidemiological aspects of systolic and pulse 
pressure
Increased PP is classically known as a surrogate of arterial stiffness in individuals 
over 50 years of age. PP is a strong independent predictor of cardiovascular 
risk, more powerful than SBP or DBP alone, particularly in the elderly |2,3|. PP 
depends on arterial stiffness and wave reflections, but also on cardiac factors such 
as ventricular ejection. Several population-based studies, mainly from France and 
the USA |3|, indicate that arterial stiffness, measured from PWV, is a more specific 
measure of risk than PP itself. This has been reinforced by two European studies, 
from Denmark and the Netherlands, published in 2006.
✍
Prognostic value of aortic pulse wave velocity as index 
of arterial stiffness in the general population
hansen TW, staessen JA, Torp-Pedersen C, et al. Circulation 2006; 113: 
664–70
Bac k g r o u n d .  in this report, a sex- and age-stratified random sample of 1678 
Danes aged 40–70 years was studied. cox regression was used to investigate 
the prognostic value of aortic pWV, office pulse pressure, and 24-h ambulatory 
pulse pressure, while adjusting for mean arterial pressure and other covariates. 
Over a median follow-up of 9.4 years, the incidence of fatal and non-fatal 
cardiovascular end-points, cardiovascular mortality, and fatal and non-fatal 
coronary heart disease, amounted to 154, 62, and 101 cases, respectively. The 
results were adjusted for sex, age, body mass index, mean arterial pressure 
measured in the office (conventional pulse pressure and pWV or by ambulatory 
monitoring (24-h pp), smoking, and alcohol intake. With these adjustments, pWV 
maintained its prognostic significance in relation to each end-point (P < 0.05), 
whereas office and 24-h pp lost their predictive value (P > 0.19), except for office 
pp in relation to coronary heart disease (P = 0.02). for each 1 – SD (standard 
deviation) increment in pWV (3.4 m/s), the risk of an event increased by 16–20%. 
in sensitivity analyses, pWV still predicted all cardiovascular events after 
standardizing to a heart rate of 60 beats per minute, after adjustment for 24-h 
Map instead of office Map, and/or after additional adjustment for the ratio of 
total to high-density lipoprotein (hDl) serum cholesterol and diabetes mellitus at 
baseline.
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I n t e r p r e t a t I o n .  in a general danish population, aortic PWV predicted a composite 
of cardiovascular outcomes above and beyond traditional cardiovascular risk factors, 
including 24-h MAP (Fig. 12.5).
✍
Arterial stiffness and risk of coronary heart disease and 
stroke: the Rotterdam Study
Mattace-raso Fus, van der Cammen TJ, hofman A, et al. Circulation 2006; 
113: 657–63
Bac k g r o u n d .  The aim of this study was to evaluate whether arterial stiffness 
is a predictor of coronary heart disease and stroke in a population-based 
study among apparently healthy subjects. The study included 2835 subjects 
participating in the third examination phase of the rotterdam Study. arterial 
stiffness was measured as aortic pWV and carotid distensibility. cox’s 
proportional hazard regression analysis was carried out to compute hazard ratios. 
During follow-up, 101 subjects developed coronary heart disease (mean follow-
up period 4.1 years) and 63 subjects developed a stroke (mean follow-up period 
3.2 years). The risk of cardiovascular disease increased with increasing aortic 
pWV. hazard ratios and corresponding 95% confidence intervals of coronary heart 
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fig. 12.5 relative hazard ratios for composite cardiovascular end-point by quintiles 
of the distribution of pulse wave velocity (PWV) and office and 24-h pulse pressure 
(unadjusted; open symbols) or with adjustment for sex and age (closed symbols). The 
hazard ratios express the risk in each quintile compared with the average risk in the 
whole population. Vertical lines denote 95% confidence intervals. P-values are for 
trend. source: hansen et al. (2006).
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disease for subjects in the second and upper tertile of the aortic pWV, compared 
with subjects in the reference category, were 1.72 (0.91–3.24) and 2.45 
(1.29–4.66), respectively, after adjustment for age, gender, Map, and heart rate. 
corresponding estimates for stroke were 1.22 (0.55–2.70) and 2.28 (1.05–4.96). 
estimates decreased only slightly after adjustment for cardiovascular risk factors, 
carotid intima–media thickness, the ankle–arm index, and pp. The aortic pWV 
provided additional predictive value above cardiovascular risk factors, measures 
of atherosclerosis and pp. carotid distensibility as measured in this study was not 
independently associated with cardiovascular disease.
I n t e r p r e t a t I o n .  Aortic PWV is an independent predictor of coronary heart disease and 
stroke in apparently healthy subjects.
Comment
The predictive value of several traditional cardiovascular risk factors may decrease 
with age, due to selective survival and the influence of comorbidity on standard 
risk factors levels. Aortic stiffness steadily increases with age and can be considered 
as a cumulative measure of previous exposures |2,3|. Values of arterial stiffness 
can be directly and non-invasively measured by PWV (Fig. 12.2), or by assessing 
vascular distensibility at a given site of the arterial tree |2,3|. In the two population-
based studies, increased aortic PWV predicted coronary heart disease and stroke 
in apparently healthy subjects. Aortic stiffness provided additional predictive value 
above standard cardiovascular risk factors, measures of atherosclerosis and pulse 
pressure, which differed markedly from that of Framingham score and was even 
additional |2,3|. The role of aortic PWV in cardiovascular risk stratification should 
be thoroughly investigated.
Clinical methods to study large artery structure and 
function
The ability to evaluate the elasticity of the arterial wall and wave reflections was 
established by the end of the nineteenth century. Although pulsatile hemodynamics 
has been widely studied using invasive techniques |2,3|, there has been debate about 
the best non-invasive method of evaluating such parameters in large populations. 
Evaluation of the various potential approaches requires a stepwise approach. First, 
the best-validated methods should be selected, i.e. PWV measurements and pulse 
wave analysis (for wave reflections) |1–3|. Second, it is important to ensure that the 
indices they provide are distinct from standard BP measurements and from the 
evaluation of endothelial function |2,3|. Third, such techniques should be applied 
(if necessary) to cardiovascular risk stratification |4|.
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✍
Arterial ultrasonography and tonometry as adjuncts to 
cardiovascular risk stratification
Kullo iJ, Malik Ar. J Am Coll Cardiol 2007; 49: 1413–26
Bac k g r o u n d .  Myocardial infarction and stroke often occur without prior 
warning in asymptomatic individuals. identifying individuals at risk is important 
for cost-effective use of preventive therapies. algorithms based on risk factors 
statistically associated with cardiovascular events classify individuals into high-
risk, intermediate-risk, or low-risk categories. however, more than one-third of 
adults in the uSa are in the intermediate-risk category, and decisions regarding 
therapy are challenging in this subset. Testing for alterations in arterial function 
and structure that predate cardiovascular events may help refine cardiovascular 
risk assessment in the intermediate-risk group and identify candidates for 
aggressive therapy. Vascular ultrasonography and tonometry are promising test 
modalities for assessment of arterial function and structure in asymptomatic 
subjects. Several prospective studies have shown that measures of arterial 
function and structure provide prognostic information incremental to conventional 
risk factors.
I n t e r p r e t a t I o n .  standardization of methodology and establishment of quality control 
standards in the performance of such tests could facilitate their integration into clinical 
practice as adjuncts to existing cardiovascular risk stratification algorithms |1–3|. The 
most important field remains to distinguish clearly between arterial stiffness and wave 
reflections and to determine the role of wave reflections in the clinical management of 
hypertension and other cardiovascular risk factors.
Comment
While PWV is becoming widely used to determine cardiovascular risk, studies of 
wave reflections are still at an early stage |1–3| and it remains to be established that 
ankle-on-brachial SBP measurements are adequate to evaluate wave reflections in 
clinical practice. It is also necessary to apply wave reflections not only to baseline 
or drug studies but, more importantly, to exercise studies |2|.
✍
Ambulatory arterial stiffness index derived from 24-h 
ambulatory blood pressure monitoring
Li y, Wang J, dolan e, et al. Hypertension 2006; 47: 359–64
Bac k g r o u n d .  a new marker of the dynamic behaviour of SBp and DBp over 
24 h has been introduced and named the ambulatory arterial stiffness index 
(aaSi). The utility of the index is based on the hypothesis that in stiffer arteries 
SBp rises significantly more than DBp in a range of Bp readings over 24 h when 
compared with a more compliant artery. The advantages of this marker are that 
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its measurement requires no special training and that it is already part of the 
classical cardiovascular risk stratification, and thus is relatively cheap. healthy 
volunteers (166) were recruited from a chinese population and subjected to 
both aaSi and carotid–femoral pWV measurement. aaSi was defined as 1 minus 
the regression slope of DBp on SBp, with readings acquired at 20-min intervals 
during the day (8 a.m. to 10 p.m.) and at 4-min intervals during the night (10 
p.m. to 8 a.m.). a further 348 participants were randomly selected from six 
villages in china to undergo aaSi measurement and peripheral waveform analysis. 
The augmentation index (aix) was determined as the ratio of the second to 
the first shoulder of the systolic upstroke. common baseline characteristics 
were determined in all participants. The validity of the findings was checked 
against a Belgian and an irish cohort enrolled in the international Database of 
ambulatory Blood pressure Monitoring. The purposes of this study seemed to be 
(i) comparison of aaSi with other measures of arterial stiffness, such as pWV 
and aix; (ii) evaluation of aaSi determinants; and (iii) analysis of an international 
database to assess distribution and normal values of aaSi.
I n t e r p r e t a t I o n .  in the 166 healthy volunteers, a close relation was found between 
PWV and AAsi (r = 0.51, P < 0.0001). Among the 348 randomly selected participants, 
32.8% were hypertensive and 14.1% used antihypertensive medication. AAsi and Aix 
increased with sex, age, and MAP, but decreased with body height. Twenty-four-hour 
heart rate was an independent determinant of Aix, but not of AAsi. serum cholesterol, 
smoking, and alcohol intake had no significant contribution. AAsi was closely correlated 
with Aix and PP. in subjects < 40 years, the correlation between AAsi and PP, but not 
between Aix and PP, remained significant. Analysis of the international database showed 
that AAsi was higher in hypertensive subjects and the upper boundary of the 95% 
confidence interval for individual prediction was 0.53 at 20 years and 0.72 at 80 years.
Comment
Ambulatory arterial stiffness index has consistent correlations with other markers 
of arterial stiffness, such as PWV and AIx. Some characteristics, such as age and 
hypertension, go hand in hand with arterial stiffness. However, the role of arterial 
stiffness in the AASI mechanism is not yet clearly demonstrated. However, AASI 
has been shown to independently predict cardiovascular risk, mostly for stroke 
|1–3|.
Central versus peripheral measurements of large 
arteries
Blood pressure is a travelling wave, largely modulated by the arterial mechanical 
properties and reflected at various sites along the arterial tree. As a consequence of 
wave travel, SBP and pulse pressure, but not MAP and DBP, are consistently higher 
(amplified) at the peripheral arteries than in central arteries |5|. This phenomenon 
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fig. 12.6 Variation of pressure wave pattern along the arterial tree |2,3|. Amplification 
(approximately 11 mmhg) is observed for systolic blood pressure and pulse pressure, 
not for mean arterial pressure or diastolic blood pressure, and is a consequence of the 
pattern of wave reflections.
is usually called SBP or pulse pressure amplification (Fig. 12.6) |1–4|. Therefore, 
while still trying to explore the role of brachial SBP and pulse pressure compared 
with DBP in the process of cardiovascular risk stratification, accumulated data over 
recent decades lead to a provocative question: are we measuring BP in the right 
place? Advances in biomedical engineering allow a more detailed investigation of 
arterial hypertension in large epidemiological studies by enabling the non-invasive 
estimation of pressure waveforms at the sites where it actually matters, namely 
the aorta and the carotid arteries |6–9|. Here, central BP and aortic stiffness will be 
successively investigated and compared with brachial artery BP measurements.
✍
Indices of pulse wave analysis are better predictors of 
left ventricular mass reduction than cuff pressure
hashimoto J, imai y, o’rourke MF. Am J Hypertens 2007; 20: 378–84
Bac k g r o u n d .  large numbers of patients are required to determine an 
association between regression of left ventricular (lV) mass and a decrease 
in brachial cuff Bp in the treatment of hypertension |1,2|. hence, there is a 
need to show the potential superiority of pulse wave analysis (central Bp 
measurements) over conventional Bp measurement in predicting treatment-
induced lV mass reduction |3,7|. forty-six untreated patients (mean age 56 ± 7 
years) with hypertension received standard medical treatment based on 
international guidelines |1–3|. echocardiography and measurements of various lV 
load indices were made before and after 1 year of treatment. antihypertensive 
treatment significantly (P < 0.05) reduced lV load, manifest by a decrease 
in measured brachial Bp, estimated aortic Bp, carotid–femoral (aortic) pWV, 
aortic augmentation index (aia), aortic augmented pressure (augp), and radial 
augmentation index (air). These changes were accompanied by a significant 
reduction in left ventricular mass index (lVMi) and improvements in systolic 
ejection fraction and diastolic early-to-atrial ratio of transmitral flow velocities. 
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The treatment-induced lVMi change was not correlated with changes in brachial 
Bp or pWV, but was closely correlated with factors influenced by wave reflection 
– changes in aia, air, augp, and aorta-to-arm pulse pressure amplification. On 
multivariate analysis, aia change was the strongest determinant of lVMi change, 
independent of brachial Bp and pWVcf changes (β = 0.51, P < 0.001). estimated 
subject numbers required for predicting a significant lVMi reduction were far less 
when wave reflection-related factors were used rather than conventional brachial 
Bp.
I n t e r p r e t a t I o n .  These results suggest that reduction in central BP wave reflection 
is an important therapeutic strategy for reducing LV mass, which can be predicted with 
modest subject numbers.
Comment
It has repeatedly been stated that variation in the reduction in cardiac mass 
experienced during long-term antihypertensive therapy seen with different drugs 
(e.g. angiotensin blockers and beta-blockers) results from a specific effect of some 
drugs on cardiac tissue that is independent of BP changes |2,3|. However, this 
interpretation holds true only for central and not for brachial BP measurements 
because central BP determinations, in contrast to brachial BP measurements, 
are highly influenced by heart damage and thus are consistently correlated with 
changes in cardiac mass |2,3,8|.
✍
Cross-sectional correlates of increased aortic stiffness 
in the community: the Framingham Heart Study
Mitchell GF, Guo Cy, Benjamin eJ, et al. Circulation 2007; 115: 2628–36
Bac k g r o u n d .  increased aortic stiffness, a typical aortic measurement 
independent of central Bp measurements, is associated with numerous common 
diseases of ageing, including heart disease, stroke, and renal disease. however, 
the prevalence and correlates of abnormally high aortic stiffness are as yet 
incompletely understood. Two aortic stiffness measures, carotid–femoral (aortic) 
pWV and forward pressure wave amplitude, were evaluated in a pooled sample 
of the framingham Original, Offspring and minority OMNi cohorts (mean age 62 
years, 56% women). abnormal values of each stiffness measure were defined as 
values exceeding the sex-specific 90th percentile of a reference group with a low 
burden of conventional cardiovascular disease risk factors. applying this criterion 
to the entire sample identified a 24–33% prevalence of abnormal stiffness 
measures. The prevalence of abnormal stiffness increased markedly with age. for 
example, pWV increased from a few per cent in patients of both sexes under 50 
years to 64% in men over 70 and to 74% in women over 70. adjusting for age, 
important correlates of abnormal aortic stiffness included higher Map, greater 
body mass index, impaired glucose metabolism, and abnormal lipids. correlates 
of aortic stiffness were similar if age-specific rather than fixed criteria for defining 
abnormal stiffness were used.
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I n t e r p r e t a t I o n .  The prevalence of abnormal aortic stiffness increases steeply with 
advancing age in the community, especially in the presence of obesity or diabetes. data 
suggest that the burden of disease attributable to aortic stiffness is likely to increase 
considerably over the next few years as the population ages.
Comment
In this pooled analysis of the community-based Framingham Original, Offspring 
and OMNI cohorts, it was found that the prevalence of abnormal stiffness, assessed 
as aortic PWV, increases from a few per cent prior to age 50 to a staggering 
70% after age 70. Similarly, the prevalence of abnormal forward pressure wave 
amplitude, a central BP parameter, increases by approximately 10-fold across the 
same age range. Such observations suggest that the burden of disease attributable 
to aortic stiffness is likely to increase considerably as the population ages. Lifestyle 
modification, risk factor intervention, or novel therapies that specifically target 
aortic stiffness may have considerable impact on the overall burden of disease in 
our ageing society |2,3|.
Systolic hypertension in the elderly and in the 
young
The hemodynamic profile of isolated systolic hypertension involves an 
SBP ≥ 140 mmHg while DBP remains normal or low |2,3|. In many patients, DBP 
may be above 90 mmHg but, even here, SBP remains disproportionally elevated for 
the level of DBP. All of these hemodynamic profiles may occur either in the elderly 
or in young people |2,3|.
✍
Diastolic blood pressure and mortality in the elderly 
with cardiovascular disease
Protogerou Ad, safar Me, iaria P, et al. Hypertension 2007; 50: 172–80
Bac k g r o u n d .  isolated systolic hypertension is predominantly observed in 
the elderly, due to increased arterial stiffness. aggressive treatment leads to 
excessive lowering of DBp and results in a J-shape curve for association with 
mortality. it is not yet known whether increased SBp after age 70 years is a 
simple epiphenomenon of increased arterial stiffness and/or of impaired cardiac 
function. aortic pWV and pressure wave reflections, measured by by pulse 
wave analysis, and cardiac function, measured by ultrasound, were assessed 
in a cohort of 331 hospitalized subjects > 70 years (mean age 85 ± 7 years). 
During a 2-year follow-up period, 110 subjects died. No association of prognosis 
with SBp, pp, or pWV was observed. a J-shape association between DBp and 
overall cardiovascular mortality was observed. unadjusted cox regression 
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analysis showed that mortality was higher among patients in the first tertile of 
DBp (≤ 60 mmhg). cox regression analysis revealed that DBp ≤ 60 mmhg was 
a predictor of mortality independent of cardiovascular status, cardiovascular 
risk factors, and drug treatment. Multivariate regression analysis showed 
that increased age and low total peripheral resistance, but not left ventricular 
function, were the cardinal determinants of low DBp. The ‘optimal’ DBp in 
subjects with isolated systolic hypertension was found to be 70 mmhg.
I n t e r p r e t a t I o n .  The study showed that, in the frail elderly, a dBP value of ≤ 60 mmhg 
is associated with reduced survival, independent of large artery stiffness and left 
ventricular function, suggesting that more rational antihypertensive therapy, not only 
based on sBP level, is needed.
Comment
Guidelines on the management of hypertension set standard goals for brachial 
BP reduction that are independent of age. All major clinical trials assessing the 
reduction in cardiovascular risk after BP-lowering antihypertensive drug treatment 
have included subjects with SBP > 160 mmHg, so there is no direct evidence to 
support the target of less than 140 mmHg. On the basis of the accumulating new 
data on the U- or J-shaped association between mortality and DBP in the elderly, 
there is a need for prospective studies focusing on ‘how low can we go’ in specific 
subgroups of the elderly, hypertensive population. Similar attempts in the past 
to define ‘low limits’ have failed, probably because they failed to go ‘low enough’, 
evaluating DBP < 60 mmHg. Until evidence-based guidelines are available, a 
more rational approach to the treatment of hypertension in elderly patients with 
cardiovascular disease seems to be necessary.
✍
Spurious systolic hypertension in young adults: 
prevalence of high brachial systolic blood pressure and 
low central pressure and its determinants
hulsen hT, nijdam Me, Bos WJ, et al. J Hypertens 2006; 24: 1027–32
Bac k g r o u n d .  The objective of this study was to investigate the prevalence 
and determinants of spurious systolic hypertension (SSh) in a population-based 
sample of young adults and estimate their 20-year risk of coronary heart disease. 
a total of 750 young adults (352 men and 398 women), aged 26–31 years, from 
the atherosclerosis risk in young adults study were enrolled. Blood pressure 
levels were measured twice and central (aortic) pressures were derived by 
applanation tonometry on the radial artery using a generalized transfer function. 
SSh was defined as brachial SBp ≥ 140 mmhg, brachial DBp < 90 mmhg, and 
central SBp < 124 mmhg for men and < 120 mmhg for women. The framingham 
risk score was calculated. analysis of variance models were used to compare 
SSh individuals with normotensive and hypertensive males for cardiovascular 
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risk factors. SSh was diagnosed in 57 men (16.1%; 95% confidence interval 
12.3–20.0%) compared with only three women (8%; 95% confidence interval 
0–1.6%). The female population was excluded from further analysis. compared 
with normotensive males, SSh individuals were heavier (88.7 kg vs. 81.8 kg, 
P < 0.05), had a higher body mass index (BMi) (25.8 vs. 24.2 kg/m2, P < 0.01), 
and had significantly higher brachial and central SBp, DBp, pp, and Map. They 
had significantly higher pp amplification. Twenty-year framingham risk scores 
based on DBp did not differ significantly between SSh subjects and normotensive 
individuals (2.72% vs. 2.10%, respectively).
I n t e r p r e t a t I o n .  spurious systolic hypertension is predominantly found among young 
adult men. Apart from weight and BMi, no other cardiovascular risk factors differed 
significantly between subjects with ssh and normotension or hypertension. When 
calculating the 20-year risk of coronary heart disease based on brachial dBP, ssh 
individuals were at intermediate risk between normotensive and hypertensive participants, 
but differences were not statistically significant.
Comment
O’Rourke et al. |2| suggested that SSH results from increased SBP amplification 
between the aorta and brachial artery, a finding which was indeed reported in the 
present paper. Others found reduced or even normal pressure amplification in their 
SSH cohort |2,3,5|. Perhaps more importantly, in all studies in subjects with systolic 
hypertension, central systolic pressures higher than in normotensive control 
subjects were observed. Such central pressures cannot be considered normal, 
because they are above the ‘usual’ value of central BP in normotensive individuals 
(estimated as < 110 mmHg from the most usual observations). Central pressure 
seems to be a better predictor of end-organ damage and cardiovascular outcomes 
|9|. Given the prevalence of spurious ‘hypertension’, it is important to establish long-
term observational studies to accurately determine the fate of such individuals.
Pulse pressure and inflammatory factors
The role of inflammatory factors in the mechanism(s) of systolic hypertension 
should be studied extensively because of their possible therapeutic consequences 
|10|. Usually, increased pulse pressure is observed with ageing and atherosclerosis 
and, thus, is related to increased arterial stiffness. However, atherosclerosis, in the 
absence of calcifications and sclerosis, is mainly associated with the presence of 
foam cells and, thus, soft tissue. Inflammation is increasingly considered as the best 
common denominator between ageing and atherosclerosis. Two recent studies on 
the subject are summarized in the last part of this chapter.
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✍
Acute systemic inflammation increases arterial stiffness 
and decreases wave reflections in healthy individuals
Vlachopoulos C, dima i, Aznaouridis K, et al. Circulation 2005; 112: 
2193–200
Bac k g r o u n d .  arterial stiffness is an important measure of arterial performance 
and an independent predictor of cardiovascular risk. low-grade inflammation 
has been implicated in the pathophysiology of atherosclerotic cardiovascular 
disease. furthermore, acute inflammatory stimuli, such as acute infections, 
are associated with a transient increased risk of cardiovascular events. arterial 
stiffness has been related to inflammatory activation in several chronic settings. 
however, there are no data to establish whether or not the relationship between 
inflammation and arterial stiffness is causative. To investigate this issue, a 
randomized, double-blind, sham procedure-controlled study was conducted in 
100 healthy individuals. The study consisted of two treatment arms, one with 
Salmonella typhi vaccination and one with sham vaccination. arterial stiffness 
and wave reflection alterations were assessed by measuring carotid–femoral pWV 
and central aix, respectively, before and 8 h and 32 h after vaccination. During 
the same time intervals, the level of inflammatory activation was evaluated 
with high-sensitivity c-reactive protein (hscrp), high-sensitivity interleukin 6 
(hsil-6), total matrix metalloproteinase-9 (MMp-9), and soluble cD-14 (scD-14). 
furthermore, in a substudy the effect of pretreatment with aspirin (1200 mg) on 
the changes of inflammatory status and arterial stiffness indices induced by acute 
inflammation was assessed. Vaccination produced a significant increase in pWV 
(at 8 h by 0.43 m/s), which returned, although not completely, to baseline values 
at 32 h. interestingly, vaccination resulted in a decrease in wave reflections 
(absolute decrease in aix of 5% at 8 h and 2.5% at 32 h), indicating peripheral 
vasodilation. These effects were associated with significant increases in hscrp, 
hsil-6, and MMp-9 at 8 h and with a prominent increase of hscrp at 32 h. aspirin 
pretreatment abrogated the effects of vaccination on pWV and aix (increase of 
0.11 m/s and 0.4%, respectively, P = NS).
I n t e r p r e t a t I o n .  The present study shows, through a cause and effect relationship, 
that acute inflammation leads to deterioration of large-artery stiffness and to a decrease 
in wave reflections.
Comment
This is the first study to establish an aetiological relationship between acute 
inflammation and deterioration of arterial stiffness. Inflammatory activation 
induced by vaccination was accompanied by an increase in PWV but, interestingly, 
by a decrease in AIx. A possible explanation for this apparent paradox may be 
the influence of peripheral vasodilation. As arterial stiffness affects the timing of 
the merging of incident and reflected waves, one would an increase in PWV to 
be accompanies by an increase in AIx. However, inflammation-induced peripheral 
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vasodilation causes a decrease in the magnitude of reflected waves, and a net 
decrease in AIx despite the increase in PWV. Importantly, aspirin significantly 
blunted the acute inflammation-induced effects on arterial properties.
✍
Interleukin 6 is associated with subclinical 
atherosclerosis: a link with soluble intercellular 
adhesion molecule 1
Amar J, Fauvel J, drouet L, et al. J Hypertens 2006; 24: 1083–8
Bac k g r o u n d .  among the markers of inflammation, a cytokine, interleukin 6 
(il-6), promotes the expression of intercellular adhesion molecule 1 (icaM-1) 
and c-reactive protein (crp) synthesis, and leads to a series of procoagulant 
actions with potential implications for the progression of atherosclerosis. The 
aim of this population-based study was to analyse the relationship between il-6 
and atherosclerotic lesions and the effect of serum icaM-1 and crp on this 
relationship. a total of 1015 individuals were randomly recruited between 1995 
and 1997 in haute-Garonne, a french region with a low cardiovascular risk; 
of these, complete data for all measurements was available for 953 subjects. 
common carotid intima–media thickness (iMT) and the presence of plaques in 
the carotid and femoral arteries were assessed by ultrasonography. quartiles of 
il-6, serum icaM-1, and crp were positively associated with plaques and iMT. 
after adjustment for traditional risk factors, il-6 (P < 0.001) and serum icaM-1 
(P < 0.002) remained positively associated with plaques but not crp (P = 0.20). 
Neither il-6, serum icaM-1, nor crp was independently associated with iMT. 
When serum icaM-1 was entered into the model in addition to traditional 
risk factors and il-6, the proportion of the variance in the number of plaques 
explained by the model did not increase significantly.
I n t e r p r e t a t I o n .  iL-6 levels are associated with subclinical atherosclerotic lesions 
independently of traditional risk factors; the influence of iL-6 on iCAM-1 secretion may 
play a role in this association. These results suggest a role for iL-6 in the stratification of 
cardiovascular risk.
Comment
The role of inflammation as a factor in both atherosclerotic disease and insulin 
resistance has been previously studied |2,3,10|. In models of diet-induced and 
genetic obesity, adipose tissue presents increased expression and content of 
proinflammatory cytokines such as IL-6. IL-6 may be form the link between 
metabolic syndrome and acute cardiovascular events. The current study adds to 
this knowledge and may contribute to the design of a new therapeutic strategy 
to prevent atherosclerotic disease at its early phase, especially in patients with 
metabolic syndrome.
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